NEW YORK, Dec. 4—Myriad Genetics and Laboratory Corporation of America Holdings announced Tuesday that LabCorp will be the genomics company’s exclusive sales and distribution partner in the US, and will market the company’s DNA-based  tests to its network of more than 200,000 primary care physician customers.

The marketing alliance covers all four of Myriad’s predictive tests, which detect common mutations in order to assess patient risk for hypertension, cardiovascular disease and certain hereditary cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.